Answers are grounded in this paper and cite their sources.
Liver transplant and resection are preferable for the management of hepatocellular carcinoma, but ultimately, tumor location, biology, and patient condition dictate treatment decisions. At the NCCN 2022 Annual Conference, a panel of experts used 3 case studies to develop an evidence-based approach to the treatment of similar patients with hepatocellular carcinoma. Moderated by Daniel B. Brown, MD, FSIR, the session focused on current research regarding liver-directed and systemic therapy options.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: